financetom
Business
financetom
/
Business
/
NVR beats fourth-quarter profit estimates on strong pricing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NVR beats fourth-quarter profit estimates on strong pricing
Jan 28, 2025 7:04 AM

Jan 28 (Reuters) - U.S. homebuilder NVR Inc ( NVR ) beat

Wall Street estimates for fourth-quarter profit on Tuesday,

helped by higher pricing of home units.

The average sales price of new orders in the fourth quarter

of 2024 was $469,000, up 4% from last year.

However, new orders for quarter ended Dec. 31 fell to 4,794

units, or about 8%, from 5,190 units last year.

NVR's earnings per share for the October-to-December quarter

came in at $139.93, above analysts' average estimates of

$127.08.

Consolidated revenues rose 17% to $2.85 billion from a year

earlier, beating estimates of $2.68 billion, according to data

compiled by LSEG.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Guyana, Suriname could supply 12 million tonnes of LNG annually in the 2030s, report says
Guyana, Suriname could supply 12 million tonnes of LNG annually in the 2030s, report says
Nov 4, 2024
Nov 4 (Reuters) - Guyana and Suriname could supply 12 million metric tonnes of liquefied natural gas annually at a competitive price by the next decade, according to a report by Wood Mackenzie on Monday. LNG demand is expected to spike by the end of the decade as industries switch from highly polluting coal to gas, which can cut greenhouse...
Zoetis Q3 Earnings Beat, Companion Animal Segment Growth Gives Confidence Into 2025: Analyst
Zoetis Q3 Earnings Beat, Companion Animal Segment Growth Gives Confidence Into 2025: Analyst
Nov 4, 2024
On Monday, Zoetis Inc’s third-quarter 2024 adjusted EPS increased 16% year over year to $1.58, beating the consensus of $1.46. The animal health firm reported sales of $2.39 billion, up 11%, beating the consensus of $2.29 billion. On an operational basis, revenue for the third quarter of 2024 increased 14% compared with the third quarter of 2023. Also Read: Elanco’s Dermatology Treatment Secures...
BioNTech Sees Full-Year Revenue at Low End of Guidance; Third-Quarter Results Rise
BioNTech Sees Full-Year Revenue at Low End of Guidance; Third-Quarter Results Rise
Nov 4, 2024
01:07 PM EST, 11/04/2024 (MT Newswires) -- BioNTech (BNTX) said on Monday that it expects full-year revenue at the low end of its guidance due in part to inventory write-downs, even as variant-adapted COVID-19 vaccines helped the German drugmaker advance third-quarter results year over year. BioNTech expects to be at the bottom end of its 2.5 billion euros ($2.72 billion)...
On Holding Seen Beating Q3 Earnings, Sales Estimates, UBS Says
On Holding Seen Beating Q3 Earnings, Sales Estimates, UBS Says
Nov 4, 2024
01:10 PM EST, 11/04/2024 (MT Newswires) -- On Holding ( ONON ) is expected to beat Q3 estimates for sales and a measure of earnings and to raise fiscal 2024 revenue growth guidance, UBS Securities said Sunday in a report. Industry data indicated the company posted high double-digit growth in US direct-to-consumer sales across all the months in Q3 and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved